1368488
2023
items
1
0
author
asc
year
1
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22instance%22%3A%22zotpress-2cac93135e301142d4731660d9ddcb26%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22UJGH7XG2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aubry%20and%20Veziris%22%2C%22parsedDate%22%3A%222023-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAubry%2C%20A.%20and%20Veziris%2C%20N.%20%282023%29.%20%3Cb%3ELa%20tuberculose%2C%20l%26%23x2019%3Bune%20des%20plus%20anciennes%20maladies%20infectieuses%26%23x202F%3B%3A%20quelles%20avanc%26%23xE9%3Bes%20r%26%23xE9%3Bcentes%20majeures%26%23x202F%3B%3F%3C%5C%2Fb%3E%20Med%20Sci%20%28Paris%29%20%3Ci%3E39%3C%5C%2Fi%3E%2C%20203%26%23x2013%3B204%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1051%5C%2Fmedsci%5C%2F2023054%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1051%5C%2Fmedsci%5C%2F2023054%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22La%20tuberculose%2C%20l%5Cu2019une%20des%20plus%20anciennes%20maladies%20infectieuses%20%3A%20quelles%20avanc%5Cu00e9es%20r%5Cu00e9centes%20majeures%20%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22m%26eacute%3Bdecine%5C%2Fsciences%20%28M%5C%2FS%29%2C%20revue%20internationale%20dans%20le%20domaine%20de%20la%20recherche%20biologique%2C%20m%26eacute%3Bdicale%20et%20en%20sant%26eacute%3B%22%2C%22date%22%3A%222023%5C%2F03%5C%2F01%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%2210.1051%5C%2Fmedsci%5C%2F2023054%22%2C%22ISSN%22%3A%220767-0974%2C%201958-5381%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.medecinesciences.org%5C%2Farticles%5C%2Fmedsci%5C%2Fabs%5C%2F2023%5C%2F03%5C%2Fmsc230068%5C%2Fmsc230068.html%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A27%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22CVEKMV76%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Barbier%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBarbier%2C%20E.%2C%20Fouchet%2C%20T.%2C%20Hartmann%2C%20A.%2C%20Cambau%2C%20E.%2C%20Mougari%2C%20F.%2C%20Dubois%2C%20C.%2C%20Lubetzki%2C%20M.%20and%20Rochelet%2C%20M.%20%282023%29.%20%3Cb%3ERapid%20electrochemical%20detection%20of%20Mycobacterium%20tuberculosis%20in%20sputum%20by%20measuring%20Ag85%20activity%20with%20disposable%20carbon%20sensors%3C%5C%2Fb%3E.%20Talanta%20%3Ci%3E253%3C%5C%2Fi%3E%2C%20123927%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.talanta.2022.123927%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.talanta.2022.123927%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rapid%20electrochemical%20detection%20of%20Mycobacterium%20tuberculosis%20in%20sputum%20by%20measuring%20Ag85%20activity%20with%20disposable%20carbon%20sensors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Barbier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Th%5Cu00e9o%22%2C%22lastName%22%3A%22Fouchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Hartmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9ment%22%2C%22lastName%22%3A%22Dubois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurice%22%2C%22lastName%22%3A%22Lubetzki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murielle%22%2C%22lastName%22%3A%22Rochelet%22%7D%5D%2C%22abstractNote%22%3A%22An%20electrochemical%20assay%20for%20the%20detection%20of%20the%20enzymatic%20activity%20of%20the%20antigen%2085%20%28Ag85%29%20tuberculosis%20%28TB%29%20biomarker%20was%20developed%20and%20evaluated%20for%20the%20qualitative%20detection%20of%20Mycobacterium%20tuberculosis%20in%20decontaminated%20sputum.%20For%20this%20purpose%2C%20the%20electroactive%20properties%20of%20both%20synthetic%20p-aminophenyl-6-O-octanoyl-3-d-glucopyranoside%20%28p-APOG%29%20substrate%20and%20p-aminophenyl-6-3-d-glucopyranoside%20%28p-APG%29%20product%20released%20after%20the%20removal%20of%20the%20octanoyl%20fatty%20acid%20by%20the%20Ag85%20were%20investigated%20with%20disposable%20carbon%20screen-printed%20electrodes%20by%20cyclic%20voltammetry.%20Since%20specific%20anodic%20responses%20were%20obtained%20for%20the%20p-APOG%20substrate%20and%20the%20p-APG%20product%2C%20the%20intensity%20of%20the%20oxidation%20peak%20of%20the%20p-APG%20%28E%5Cu00a0%3D%5Cu00a0%2B%200.35%5Cu00a0V%20vs.%20Ag%5C%2FAgCl%29%20was%20selected%20as%20the%20analytical%20response%20for%20the%20detection%20of%20the%20Ag85%20acyltransferase%20activity.%20Once%20the%20proof%20of%20concept%20of%20the%20Ag85%20electrochemical%20assay%20was%20validated%20with%20a%20commercially-available%20Ag85B%20protein%2C%20its%20specificity%20was%20further%20assessed%20by%20analyzing%20pure%20cultures%20of%20various%20bacteria%20including%20tuberculous%20and%20non-tuberculous%20mycobacteria%20as%20well%20as%20different%20species%20found%20in%20patients%27%20sputum.%20Finally%2C%20with%20a%20specificity%20of%2078%25%20and%20a%20sensitivity%20of%2089%25%2C%20the%20method%20was%20successfully%20compared%20to%20microscopy%20and%20culture%20routine%20tests%20for%20TB%20testing%20in%2036%20frozen%20fluidized%20and%20decontaminated%20sputum.%20This%20suggests%20that%20owing%20to%20its%20convenience%2C%20rapidity%2C%20low-cost%20and%20portability%2C%20the%20reported%20Ag85%20electrochemical%20assay%20is%20a%20promising%20tool%20to%20screen%20patients%20for%20TB.%22%2C%22date%22%3A%222023-02-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.talanta.2022.123927%22%2C%22ISSN%22%3A%220039-9140%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0039914022007238%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A13%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22CPD8NT5H%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Campbell%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECampbell%2C%20J.%20R.%2C%20Chan%2C%20E.%20D.%2C%20Anderson%2C%20L.%20F.%2C%20Bonnet%2C%20M.%2C%20Brode%2C%20S.%20K.%2C%20Cegielski%2C%20J.%20P.%2C%20Guglielmetti%2C%20L.%2C%20Singla%2C%20R.%2C%20Fox%2C%20G.%20J.%2C%20Skrahina%2C%20A.%2C%20Rodrigues%2C%20D.%2C%20Kuksa%2C%20L.%2C%20Viiklepp%2C%20P.%20and%20Menzies%2C%20D.%20%282023%29.%20%3Cb%3EAssociation%20of%20smoking%20and%20alcohol%20use%20with%20rifampin-resistant%20TB%20treatment%20outcomes%3C%5C%2Fb%3E.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%3Ci%3E27%3C%5C%2Fi%3E%2C%20338%26%23x2013%3B340%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0678%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0678%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20smoking%20and%20alcohol%20use%20with%20rifampin-resistant%20TB%20treatment%20outcomes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20R.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20D.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20F.%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20P.%22%2C%22lastName%22%3A%22Cegielski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20J.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-04-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.22.0678%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A41%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22Q5BS6SYV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Dom%5Cu00ednguez%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-28%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDom%26%23xED%3Bnguez%2C%20Jos%26%23xE9%3B%2C%20Boeree%2C%20M.%20J.%2C%20Cambau%2C%20E.%2C%20Chesov%2C%20D.%2C%20Conradie%2C%20F.%2C%20Cox%2C%20V.%2C%20Dheda%2C%20K.%2C%20Dudnyk%2C%20A.%2C%20Farhat%2C%20M.%20R.%2C%20Gagneux%2C%20S.%2C%20Grobusch%2C%20M.%20P.%2C%20Gr%26%23xF6%3Bschel%2C%20M.%20I.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Lange%2C%20B.%2C%20van%20Leth%2C%20F.%2C%20Lienhardt%2C%20C.%2C%20Mandalakas%2C%20Anna%20M%2C%20Maurer%2C%20F.%20P.%2C%20Merker%2C%20M.%2C%20Miotto%2C%20P.%2C%20Molina-Moya%2C%20B.%2C%20Morel%2C%20F.%2C%20Niemann%2C%20S.%2C%20Veziris%2C%20N.%2C%20Whitelaw%2C%20A.%2C%20Horsburgh%2C%20Charles%20R%2C%20Lange%2C%20C.%2C%20Dom%26%23xED%3Bnguez%2C%20Jose%2C%20Boeree%2C%20M.%20J.%2C%20Cambau%2C%20E.%2C%20Chesov%2C%20D.%2C%20Conradie%2C%20F.%2C%20Cox%2C%20V.%2C%20Dheda%2C%20K.%2C%20Dudnyk%2C%20A.%2C%20Farhat%2C%20M.%20R.%2C%20Gagneux%2C%20S.%2C%20Grobusch%2C%20M.%20P.%2C%20Gr%26%23xF6%3Bschel%2C%20M.%20I.%2C%20Guglielmetti%2C%20L.%2C%20Kontsevaya%2C%20I.%2C%20Lange%2C%20B.%2C%20van%20Leth%2C%20F.%2C%20Lienhardt%2C%20C.%2C%20Mandalakas%2C%20Anna%20Maria%2C%20Maurer%2C%20F.%2C%20Merker%2C%20M.%2C%20Miotto%2C%20P.%2C%20Molina-Moya%2C%20B.%2C%20Morel%2C%20F.%2C%20Niemann%2C%20S.%2C%20Veziris%2C%20N.%2C%20Whitelaw%2C%20A.%2C%20Horsburgh%2C%20Charles%20Robert%20and%20Lange%2C%20C.%20%282023%29.%20%3Cb%3EClinical%20implications%20of%20molecular%20drug%20resistance%20testing%20for%20Mycobacterium%20tuberculosis%3A%20a%202023%20TBnet%5C%2FRESIST-TB%20consensus%20statement%3C%5C%2Fb%3E.%20The%20Lancet%20Infectious%20Diseases%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900875-1%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900875-1%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20implications%20of%20molecular%20drug%20resistance%20testing%20for%20Mycobacterium%20tuberculosis%3A%20a%202023%20TBnet%5C%2FRESIST-TB%20consensus%20statement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Dom%5Cu00ednguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20J%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Conradie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%20R%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20P%22%2C%22lastName%22%3A%22Grobusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20I%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Lienhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20M%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%20P%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Merker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Miotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Molina-Moya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Whitelaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20R%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Dom%5Cu00ednguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20J.%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitru%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Conradie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maha%20R.%22%2C%22lastName%22%3A%22Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20P.%22%2C%22lastName%22%3A%22Grobusch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20I.%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%22%2C%22lastName%22%3A%22Kontsevaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Berit%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Lienhardt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20Maria%22%2C%22lastName%22%3A%22Mandalakas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Merker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paolo%22%2C%22lastName%22%3A%22Miotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Molina-Moya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Whitelaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20Robert%22%2C%22lastName%22%3A%22Horsburgh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22Drug-resistant%20tuberculosis%20is%20a%20substantial%20health-care%20concern%20worldwide.%20Despite%20culture-based%20methods%20being%20considered%20the%20gold%20standard%20for%20drug%20susceptibility%20testing%2C%20molecular%20methods%20provide%20rapid%20information%20about%20the%20Mycobacterium%20tuberculosis%20mutations%20associated%20with%20resistance%20to%20anti-tuberculosis%20drugs.%20This%20consensus%20document%20was%20developed%20on%20the%20basis%20of%20a%20comprehensive%20literature%20search%2C%20by%20the%20TBnet%20and%20RESIST-TB%20networks%2C%20about%20reporting%20standards%20for%20the%20clinical%20use%20of%20molecular%20drug%20susceptibility%20testing.%20Review%20and%20the%20search%20for%20evidence%20included%20hand-searching%20journals%20and%20searching%20electronic%20databases.%20The%20panel%20identified%20studies%20that%20linked%20mutations%20in%20genomic%20regions%20of%20M%20tuberculosis%20with%20treatment%20outcome%20data.%20Implementation%20of%20molecular%20testing%20for%20the%20prediction%20of%20drug%20resistance%20in%20M%20tuberculosis%20is%20key.%20Detection%20of%20mutations%20in%20clinical%20isolates%20has%20implications%20for%20the%20clinical%20management%20of%20patients%20with%20multidrug-resistant%20or%20rifampicin-resistant%20tuberculosis%2C%20especially%20in%20situations%20when%20phenotypic%20drug%20susceptibility%20testing%20is%20not%20available.%20A%20multidisciplinary%20team%20including%20clinicians%2C%20microbiologists%2C%20and%20laboratory%20scientists%20reached%20a%20consensus%20on%20key%20questions%20relevant%20to%20molecular%20prediction%20of%20drug%20susceptibility%20or%20resistance%20to%20M%20tuberculosis%2C%20and%20their%20implications%20for%20clinical%20practice.%20This%20consensus%20document%20should%20help%20clinicians%20in%20the%20management%20of%20patients%20with%20tuberculosis%2C%20providing%20guidance%20for%20the%20design%20of%20treatment%20regimens%20and%20optimising%20outcomes.%22%2C%22date%22%3A%222023-02-28%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2822%2900875-1%22%2C%22ISSN%22%3A%221473-3099%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1473309922008751%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T14%3A55%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22AU84RBBM%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Faury%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFaury%2C%20H.%20B.%2C%20Awad%2C%20Z.%2C%20Jolivet%2C%20S.%2C%20Neindre%2C%20K.%20L.%2C%20Couturier%2C%20J.%2C%20Godmer%2C%20A.%2C%20Colle%2C%20R.%2C%20Levi%2C%20L.%20I.%2C%20Cambau%2C%20E.%20and%20Barbut%2C%20F.%20%282023%29.%20%3Cb%3EInvestigation%20of%20a%20Mycobacterium%20fortuitum%20catheter-related%20bloodstream%20infection%20in%20an%20oncology%20unit%3C%5C%2Fb%3E.%20Infection%20Control%20%26amp%3B%20Hospital%20Epidemiology%201%26%23x2013%3B3%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2Fice.2022.263%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2Fice.2022.263%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Investigation%20of%20a%20Mycobacterium%20fortuitum%20catheter-related%20bloodstream%20infection%20in%20an%20oncology%20unit%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%20B.%22%2C%22lastName%22%3A%22Faury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zeina%22%2C%22lastName%22%3A%22Awad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Jolivet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Killian%20Le%22%2C%22lastName%22%3A%22Neindre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Couturier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Godmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rapha%5Cu00ebl%22%2C%22lastName%22%3A%22Colle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20I.%22%2C%22lastName%22%3A%22Levi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Barbut%22%7D%5D%2C%22abstractNote%22%3A%22We%20describe%20a%20case%20of%20healthcare-associated%20bloodstream%20infection%20due%20to%20Mycobacterium%20fortuitum.%20Whole-genome%20sequencing%20showed%20that%20the%20same%20strain%20was%20isolated%20from%20the%20shared%20shower%20water%20of%20the%20unit.%20Nontuberculous%20mycobacteria%20frequently%20contaminate%20hospital%20water%20networks.%20Preventative%20actions%20are%20needed%20to%20reduce%20the%20exposure%20risk%20for%20immunocompromised%20patients.%22%2C%22date%22%3A%222023%5C%2F02%5C%2F20%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1017%5C%2Fice.2022.263%22%2C%22ISSN%22%3A%220899-823X%2C%201559-6834%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.cambridge.org%5C%2Fcore%5C%2Fjournals%5C%2Finfection-control-and-hospital-epidemiology%5C%2Farticle%5C%2Finvestigation-of-a-mycobacterium-fortuitum-catheterrelated-bloodstream-infection-in-an-oncology-unit%5C%2F0A096CBD5D3C84B62E43DDE1CF70D660%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T15%3A07%3A16Z%22%7D%7D%2C%7B%22key%22%3A%226C4G5QVS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fr%5Cu00f6berg%20et%20al.%22%2C%22parsedDate%22%3A%222023-02-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EFr%26%23xF6%3Bberg%2C%20G.%2C%20Maurer%2C%20F.%20P.%2C%20Chryssanthou%2C%20E.%2C%20Fernstr%26%23xF6%3Bm%2C%20L.%2C%20Benmansour%2C%20H.%2C%20Boarbi%2C%20S.%2C%20Mengshoel%2C%20A.%20T.%2C%20Keller%2C%20P.%20M.%2C%20Viveiros%2C%20M.%2C%20Machado%2C%20D.%2C%20Fitzgibbon%2C%20M.%20M.%2C%20Mok%2C%20S.%2C%20Werngren%2C%20J.%2C%20Cirillo%2C%20D.%20M.%2C%20Alcaide%2C%20F.%2C%20Hyyryl%26%23xE4%3Binen%2C%20H.-L.%2C%20Aubry%2C%20A.%2C%20Andres%2C%20S.%2C%20Nadarajan%2C%20D.%2C%20Svensson%2C%20E.%2C%20Turnidge%2C%20J.%2C%20Giske%2C%20C.%20G.%2C%20Kahlmeter%2C%20G.%2C%20Cambau%2C%20E.%2C%20van%20Ingen%2C%20J.%20and%20Sch%26%23xF6%3Bn%2C%20T.%20%282023%29.%20%3Cb%3ETowards%20clinical%20breakpoints%20for%20non-tuberculous%20mycobacteria%20%26%23x2013%3B%20Determination%20of%20epidemiological%20cut%20off%20values%20for%20the%20Mycobacterium%20avium%20complex%20and%20Mycobacterium%20abscessus%20using%20broth%20microdilution%3C%5C%2Fb%3E.%20Clinical%20Microbiology%20and%20Infection%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2023.02.007%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2023.02.007%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Towards%20clinical%20breakpoints%20for%20non-tuberculous%20mycobacteria%20%5Cu2013%20Determination%20of%20epidemiological%20cut%20off%20values%20for%20the%20Mycobacterium%20avium%20complex%20and%20Mycobacterium%20abscessus%20using%20broth%20microdilution%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gabrielle%22%2C%22lastName%22%3A%22Fr%5Cu00f6berg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%20P.%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erja%22%2C%22lastName%22%3A%22Chryssanthou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louise%22%2C%22lastName%22%3A%22Fernstr%5Cu00f6m%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanaa%22%2C%22lastName%22%3A%22Benmansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samira%22%2C%22lastName%22%3A%22Boarbi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Torunn%22%2C%22lastName%22%3A%22Mengshoel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20Michael%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%20M.%22%2C%22lastName%22%3A%22Fitzgibbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simone%22%2C%22lastName%22%3A%22Mok%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jim%22%2C%22lastName%22%3A%22Werngren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Alcaide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanne-Leena%22%2C%22lastName%22%3A%22Hyyryl%5Cu00e4inen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00f6nke%22%2C%22lastName%22%3A%22Andres%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darshaalini%22%2C%22lastName%22%3A%22Nadarajan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%22%2C%22lastName%22%3A%22Svensson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Turnidge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%20G.%22%2C%22lastName%22%3A%22Giske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunnar%22%2C%22lastName%22%3A%22Kahlmeter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Sch%5Cu00f6n%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnFor%20non-tuberculous%20mycobacteria%20%28NTM%29%2C%20minimum%20inhibitory%20concentration%20%28MIC%29%20distributions%20of%20wild-type%20isolates%20have%20not%20been%20systematically%20evaluated%20despite%20their%20importance%20for%20establishing%20antimicrobial%20susceptibility%20testing%20%28AST%29%20breakpoints.%5CnMethods%5CnWe%20gathered%20MIC%20distributions%20for%20drugs%20used%20against%20the%20Mycobacterium%20avium%20complex%20%28MAC%29%20and%20Mycobacterium%20abscessus%20%28MAB%29%20obtained%20by%20commercial%20broth%20microdilution%20%28SLOMYCOI%20and%20RAPMYCOI%29%20from%2012%20laboratories.%20Epidemiological%20cut-off%20values%20%28ECOFFs%29%20and%20tentative%20ECOFFs%20%28TECOFFs%29%20were%20determined%20by%20EUCAST%20methodology%20including%20quality%20control%20%28QC%29%20strains.%5CnResults%5CnThe%20clarithromycin%20ECOFF%20was%2016%20mg%5C%2FL%20for%20M.%20avium%20%28n%3D1271%29%20whereas%20TECOFFs%20were%208%20mg%5C%2FL%20for%20M.%20intracellulare%20%28n%3D415%29%20and%201%20mg%5C%2FL%20for%20MAB%20%28n%3D1014%29%20confirmed%20by%20analysing%20MAB%20subspecies%20without%20inducible%20macrolide%20resistance%20%28n%3D235%29.%20For%20amikacin%2C%20the%20ECOFFs%20were%2064%20mg%5C%2FL%20for%20MAC%20and%20MAB.%20For%20moxifloxacin%2C%20the%20WT%20spanned%20%3E8%20mg%5C%2FL%20for%20both%20MAC%20and%20MAB.%20For%20linezolid%2C%20the%20ECOFF%20and%20TECOFF%20were%2064%20mg%5C%2FL%20for%20M.%20avium%20and%20M.%20intracellulare%2C%20respectively.%20Current%20CLSI%20breakpoints%20for%20amikacin%20%2816%20mg%5C%2FL%29%2C%20moxifloxacin%20%281%20mg%5C%2FL%29%20and%20linezolid%20%288%20mg%5C%2FL%29%20divided%20the%20corresponding%20WT%20distributions.%20For%20QC%20M.%20avium%20and%20M.%20peregrinum%2C%20%5Cu226595%25%20of%20MIC%20values%20were%20well%20within%20recommended%20QC%20ranges.%5CnConclusion%5CnAs%20a%20first%20step%20towards%20clinical%20breakpoints%20for%20NTM%2C%20%28T%29ECOFFs%20were%20defined%20for%20several%20antimicrobials%20against%20MAC%20and%20MAB.%20Broad%20wild-type%20MIC%20distributions%20indicate%20a%20need%20for%20further%20method%20refinement%20which%20is%20now%20under%20development%20within%20the%20EUCAST%20subcommittee%20for%20anti-mycobacterial%20drug%20susceptibility%20testing.%20In%20addition%2C%20we%20showed%20that%20several%20CLSI%20NTM%20breakpoints%20are%20not%20consistent%20in%20relation%20to%20the%20%28T%29ECOFFs.%22%2C%22date%22%3A%222023-02-20%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2023.02.007%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1198743X23000605%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T15%3A07%3A00Z%22%7D%7D%2C%7B%22key%22%3A%2227ERGIBY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00fcnther%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EG%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Leu%2C%20C.%2C%20Lange%2C%20C.%2C%20van%20Leth%2C%20F.%2C%20Hasan%20Hafizi%2C%20Khachatryan%2C%20N.%2C%20Aroyan%2C%20H.%2C%20Kabasakalyan%2C%20E.%2C%20Knappik%2C%20M.%2C%20Skrahina%2C%20A.%2C%20Klimuk%2C%20D.%2C%20Nikolenka%2C%20A.%2C%20Muylle%2C%20I.%2C%20Milanov%2C%20V.%2C%20Velkovska%2C%20D.%2C%20Tarinska%2C%20N.%2C%20Bachiyska%2C%20E.%2C%20Jankovic%2C%20M.%2C%20Pieridou%2C%20D.%2C%20Adamide%2C%20T.%2C%20Nicolaou%2C%20N.%2C%20Vasakova%2C%20M.%2C%20Sukholytka%2C%20M.%2C%20Kopeck%26%23xE0%3B%2C%20E.%2C%20Folkvardsen%2C%20D.%20B.%2C%20Svensson%2C%20E.%2C%20Danilovits%2C%20M.%2C%20Kummik%2C%20T.%2C%20Vasankari%2C%20T.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Nahmiash%2C%20A.%2C%20Togonidze%2C%20T.%2C%20Avaliani%2C%20Z.%2C%20Kinkladze%2C%20I.%2C%20Aspindzelashvili%2C%20R.%2C%20Bichashvili%2C%20T.%2C%20Losaberidze%2C%20G.%2C%20Merabishvili%2C%20T.%2C%20Kalsdorf%2C%20B.%2C%20Manika%2C%20K.%2C%20Tsiakitzis%2C%20K.%2C%20Bakos%2C%20A.%2C%20%26%23xC6%3Bgisd%26%23xF3%3Bttir%2C%20T.%20R.%2C%20Michelsen%2C%20G.%20S.%2C%20Karlsd%26%23xF3%3Bttir%2C%20K.%2C%20McLaughlin%2C%20A.-M.%2C%20Fitzgibbon%2C%20M.%2C%20Chemtob%2C%20D.%2C%20Codecasa%2C%20L.%20R.%2C%20Ferrarese%2C%20M.%2C%20Torri%2C%20S.%2C%20Gjocaj%2C%20M.%2C%20Kuksa%2C%20L.%2C%20Davidaviciene%2C%20E.%2C%20Wirtz%2C%20G.%2C%20Perrin%2C%20M.%2C%20Asciak%2C%20A.%20P.%2C%20Chesov%2C%20D.%2C%20de%20Lange%2C%20W.%2C%20Akkerman%2C%20O.%2C%20Poposka%2C%20B.%20I.%2C%20Mack%2C%20U.%2C%20Jensenius%2C%20M.%2C%20Kvalvik%2C%20L.%2C%20Mengshoel%2C%20A.%20T.%2C%20Kruczak%2C%20K.%2C%20Duarte%2C%20R.%2C%20Ribeiro%2C%20N.%2C%20Ibraim%2C%20E.%2C%20Kaluzhenina%2C%20A.%2C%20Barkanova%2C%20O.%2C%20Pesut%2C%20D.%2C%20Solovic%2C%20I.%2C%20Svetina%2C%20P.%2C%20Souza-Galv%26%23xE3%3Bo%2C%20M.-L.%20de%2C%20Millet%2C%20J.-P.%2C%20Casas%2C%20X.%2C%20Vives%2C%20M.%2C%20Bruchfeld%2C%20J.%2C%20Dalemo%2C%20P.%2C%20Jonsson%2C%20J.%2C%20Aeschbacher%2C%20K.%2C%20Keller%2C%20P.%2C%20%26%23xD6%3Bzkara%2C%20S.%2C%20Tiberi%2C%20S.%2C%20Chen%2C%20C.%2C%20Terleeva%2C%20Y.%20and%20Dudnyk%2C%20A.%20%282023%29.%20%3Cb%3EAvailability%20and%20costs%20of%20medicines%20for%20the%20treatment%20of%20tuberculosis%20in%20Europe%3C%5C%2Fb%3E.%20Clinical%20Microbiology%20and%20Infection%20%3Ci%3E29%3C%5C%2Fi%3E%2C%2077%26%23x2013%3B84%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2022.07.026%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2022.07.026%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20and%20costs%20of%20medicines%20for%20the%20treatment%20of%20tuberculosis%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claude%22%2C%22lastName%22%3A%22Leu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Hasan%20Hafizi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naira%22%2C%22lastName%22%3A%22Khachatryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harut%22%2C%22lastName%22%3A%22Aroyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eduard%22%2C%22lastName%22%3A%22Kabasakalyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Knappik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dzmitry%22%2C%22lastName%22%3A%22Klimuk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Nikolenka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inge%22%2C%22lastName%22%3A%22Muylle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladimir%22%2C%22lastName%22%3A%22Milanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Desislava%22%2C%22lastName%22%3A%22Velkovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neli%22%2C%22lastName%22%3A%22Tarinska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeta%22%2C%22lastName%22%3A%22Bachiyska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Despo%22%2C%22lastName%22%3A%22Pieridou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tonia%22%2C%22lastName%22%3A%22Adamide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicos%22%2C%22lastName%22%3A%22Nicolaou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Vasakova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariia%22%2C%22lastName%22%3A%22Sukholytka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilia%22%2C%22lastName%22%3A%22Kopeck%5Cu00e0%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dorte%20Bek%22%2C%22lastName%22%3A%22Folkvardsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%22%2C%22lastName%22%3A%22Svensson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manfred%22%2C%22lastName%22%3A%22Danilovits%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiina%22%2C%22lastName%22%3A%22Kummik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuula%22%2C%22lastName%22%3A%22Vasankari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Audrey%22%2C%22lastName%22%3A%22Nahmiash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamar%22%2C%22lastName%22%3A%22Togonidze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zaza%22%2C%22lastName%22%3A%22Avaliani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Inga%22%2C%22lastName%22%3A%22Kinkladze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rusudan%22%2C%22lastName%22%3A%22Aspindzelashvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Teona%22%2C%22lastName%22%3A%22Bichashvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gulnazi%22%2C%22lastName%22%3A%22Losaberidze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsitsino%22%2C%22lastName%22%3A%22Merabishvili%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Kalsdorf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katerina%22%2C%22lastName%22%3A%22Manika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karyofyllis%22%2C%22lastName%22%3A%22Tsiakitzis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agnes%22%2C%22lastName%22%3A%22Bakos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tinna%20R%5Cu00e1n%22%2C%22lastName%22%3A%22%5Cu00c6gisd%5Cu00f3ttir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gu%5Cu00f0r%5Cu00fan%20Svanhv%5Cu00edt%22%2C%22lastName%22%3A%22Michelsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Krist%5Cu00edn%22%2C%22lastName%22%3A%22Karlsd%5Cu00f3ttir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Marie%22%2C%22lastName%22%3A%22McLaughlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Fitzgibbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Chemtob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20R.%22%2C%22lastName%22%3A%22Codecasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maurizio%22%2C%22lastName%22%3A%22Ferrarese%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Torri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Majlinda%22%2C%22lastName%22%3A%22Gjocaj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edita%22%2C%22lastName%22%3A%22Davidaviciene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gil%22%2C%22lastName%22%3A%22Wirtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monique%22%2C%22lastName%22%3A%22Perrin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Analita%20Pace%22%2C%22lastName%22%3A%22Asciak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dumitri%22%2C%22lastName%22%3A%22Chesov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wiel%22%2C%22lastName%22%3A%22de%20Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Onno%22%2C%22lastName%22%3A%22Akkerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Biljana%20Ilievska%22%2C%22lastName%22%3A%22Poposka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrich%22%2C%22lastName%22%3A%22Mack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mogens%22%2C%22lastName%22%3A%22Jensenius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lajla%22%2C%22lastName%22%3A%22Kvalvik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20Torunn%22%2C%22lastName%22%3A%22Mengshoel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katarzyna%22%2C%22lastName%22%3A%22Kruczak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Ribeiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elmira%22%2C%22lastName%22%3A%22Ibraim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%22%2C%22lastName%22%3A%22Kaluzhenina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Barkanova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dragica%22%2C%22lastName%22%3A%22Pesut%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ivan%22%2C%22lastName%22%3A%22Solovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petra%22%2C%22lastName%22%3A%22Svetina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria-Luiza%20de%22%2C%22lastName%22%3A%22Souza-Galv%5Cu00e3o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan-Pau%22%2C%22lastName%22%3A%22Millet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavi%22%2C%22lastName%22%3A%22Casas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Montserrat%22%2C%22lastName%22%3A%22Vives%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Judith%22%2C%22lastName%22%3A%22Bruchfeld%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paulina%22%2C%22lastName%22%3A%22Dalemo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerker%22%2C%22lastName%22%3A%22Jonsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katrin%22%2C%22lastName%22%3A%22Aeschbacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seref%22%2C%22lastName%22%3A%22%5Cu00d6zkara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christabelle%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yana%22%2C%22lastName%22%3A%22Terleeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrii%22%2C%22lastName%22%3A%22Dudnyk%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%5CnTo%20evaluate%20the%20access%20to%20comprehensive%20diagnostics%20and%20novel%20antituberculosis%20medicines%20in%20European%20countries.%5CnMethods%5CnWe%20investigated%20the%20access%20to%20genotypic%20and%20phenotypic%20Mycobacterium%20tuberculosis%20drug%20susceptibility%20testing%20and%20the%20availability%20of%20antituberculosis%20drugs%20and%20calculated%20the%20cost%20of%20drugs%20and%20treatment%20regimens%20at%20major%20tuberculosis%20treatment%20centres%20in%20countries%20of%20the%20WHO%20European%20region%20where%20rates%20of%20drug-resistant%20tuberculosis%20are%20the%20highest%20among%20all%20WHO%20regions.%20Results%20were%20stratified%20by%20middle-income%20and%20high-income%20countries.%5CnResults%5CnOverall%2C%2043%20treatment%20centres%20from%2043%20countries%20participated%20in%20the%20study.%20For%20WHO%20group%20A%20drugs%2C%20the%20frequency%20of%20countries%20with%20the%20availability%20of%20phenotypic%20drug%20susceptibility%20testing%20was%20as%20follows%3A%20%28a%29%2075%25%20%2830%5C%2F40%29%20for%20levofloxacin%2C%20%28b%29%2082%25%20%2833%5C%2F40%29%20for%20moxifloxacin%2C%20%28c%29%2048%25%20%2819%5C%2F40%29%20for%20bedaquiline%2C%20and%20%28d%29%2072%25%20%2829%5C%2F40%29%20for%20linezolid.%20Overall%2C%20of%20the%2043%20countries%2C%2036%20%2884%25%29%20and%2024%20%2856%25%29%20countries%20had%20access%20to%20bedaquiline%20and%20delamanid%2C%20respectively%2C%20whereas%20only%206%20%2814%25%29%20countries%20had%20access%20to%20rifapentine.%20The%20treatment%20of%20patients%20with%20extensively%20drug-resistant%20tuberculosis%20with%20a%20regimen%20including%20a%20carbapenem%20was%20available%20only%20in%2017%20%2840%25%29%20of%20the%2043%20countries.%20The%20median%20cost%20of%20regimens%20for%20drug-susceptible%20tuberculosis%2C%20multidrug-resistant%5C%2Frifampicin-resistant%20tuberculosis%20%28shorter%20regimen%2C%20including%20bedaquiline%20for%206%5Cu00a0months%29%2C%20and%20extensively%20drug-resistant%20tuberculosis%20%28including%20bedaquiline%2C%20delamanid%2C%20and%20a%20carbapenem%29%20were%20%5Cu20ac44%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac15%5Cu2013152%29%2C%20%5Cu20ac764%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac542%5Cu201315152%29%2C%20and%20%5Cu20ac8709%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac7965%5Cu201311759%29%20in%20middle-income%20countries%20%28n%5Cu00a0%3D%5Cu00a012%29%20and%20%5Cu20ac280%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac78%5Cu20131084%29%2C%20%5Cu20ac29765%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac11116%5Cu201340584%29%2C%20and%20%5Cu20ac217591%20%28minimum%5Cu2013maximum%2C%20%5Cu20ac82827%5Cu2013320146%29%20in%20high-income%20countries%20%28n%5Cu00a0%3D%5Cu00a029%29%2C%20respectively.%5CnDiscussion%5CnIn%20countries%20of%20the%20WHO%20European%20region%2C%20there%20is%20a%20widespread%20lack%20of%20drug%20susceptibility%20testing%20capacity%20to%20new%20and%20repurposed%20antituberculosis%20drugs%2C%20lack%20of%20access%20to%20essential%20medications%20in%20several%20countries%2C%20and%20a%20high%20cost%20for%20the%20treatment%20of%20drug-resistant%20tuberculosis.%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2022.07.026%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1198743X22003949%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-12-28T16%3A07%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22CUDV3QRA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22G%5Cu00fcnther%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EG%26%23xFC%3Bnther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Leu%2C%20C.%2C%20van%20Leth%2C%20F.%20and%20Lange%2C%20C.%20%282023%29.%20%3Cb%3ERelative%20cost%20of%20multidrug-resistant%20TB%20medicines%20in%20Europe%3C%5C%2Fb%3E.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%3Ci%3E27%3C%5C%2Fi%3E%2C%20341%26%23x2013%3B344%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0026%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.23.0026%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Relative%20cost%20of%20multidrug-resistant%20TB%20medicines%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22G%5Cu00fcnther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Leu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22van%20Leth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-05-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.23.0026%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A40%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22WNCRMSUT%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guthmann%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuthmann%2C%20J.-P.%2C%20Fraisse%2C%20P.%2C%20Bonnet%2C%20I.%20and%20Robert%2C%20J.%20%282023%29.%20%3Cb%3EActive%20tuberculosis%20screening%20among%20the%20displaced%20population%20fleeing%20Ukraine%2C%20France%2C%20February%20to%20October%202022%3C%5C%2Fb%3E.%20Eurosurveillance%20%3Ci%3E28%3C%5C%2Fi%3E%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Active%20tuberculosis%20screening%20among%20the%20displaced%20population%20fleeing%20Ukraine%2C%20France%2C%20February%20to%20October%202022%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Guthmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Fraisse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22Persons%20fleeing%20Ukraine%20since%20February%202022%20have%20potentially%20higher%20risk%20of%20tuberculosis%20%28TB%29%20vs%20all%20European%20Union%20countries.%20Interest%20of%20active%20TB%20screening%20among%20this%20population%20is%20debated%20and%20not%20widely%20adopted.%20In%20this%20screening%20intervention%20by%20a%20network%20of%20TB%20centres%20in%20France%2C%20the%20number%20needed%20to%20screen%20%28NNS%29%20was%20862%20to%20find%20one%20case.%20This%20experience%20shows%20that%20this%20strategy%20may%20be%20relevant%20for%20TB%20control%20in%20situations%20of%20massive%20displacement%2C%20similar%20to%20that%20following%20the%20Russian%20invasion.%22%2C%22date%22%3A%222023-03-23%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.2807%5C%2F1560-7917.ES.2023.28.12.2300155%22%2C%22ISSN%22%3A%221560-7917%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.eurosurveillance.org%5C%2Fcontent%5C%2F10.2807%5C%2F1560-7917.ES.2023.28.12.2300155%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-27T15%3A02%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22RXB29UUU%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hamon%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHamon%2C%20A.%2C%20Liegeon%2C%20G.%2C%20Louis%2C%20K.%2C%20Cambau%2C%20E.%20and%20De%20Castro%2C%20N.%20%282023%29.%20%3Cb%3EAtypical%20presentation%20of%20Mycobacterium%20xenopi%20pulmonary%20infection%20in%20a%20kidney%20transplant%20recipient%3A%20A%20case%20report%20and%20literature%20review%3C%5C%2Fb%3E.%20IDCases%20%3Ci%3E31%3C%5C%2Fi%3E%2C%20e01675%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idcr.2022.e01675%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.idcr.2022.e01675%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Atypical%20presentation%20of%20Mycobacterium%20xenopi%20pulmonary%20infection%20in%20a%20kidney%20transplant%20recipient%3A%20A%20case%20report%20and%20literature%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antoine%22%2C%22lastName%22%3A%22Hamon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffroy%22%2C%22lastName%22%3A%22Liegeon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K%5Cu00e9vin%22%2C%22lastName%22%3A%22Louis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22De%20Castro%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnMycobacterium%20xenopi%20is%20one%20of%20the%20most%20common%20pathogens%20responsible%20for%20non-tuberculosis%20mycobacteria%20%28NTM%29%20pulmonary%20diseases%2C%20which%20are%20associated%20with%20poor%20prognosis%20in%20immunocompromised%20patients.%5CnCase%20presentation%5CnWe%20report%20the%20unusual%20case%20of%20a%2044-year-old%20kidney%20transplant%20recipient%20with%20multiple%20pulmonary%20nodules%20revealing%20M.%20xenopi%20pulmonary%20disease%20with%20atypical%20presentation.%20A%20three%20drug-regimen%20containing%20moxifloxacin%2C%20ethambutol%20and%20azithromycin%20was%20prescribed%2C%20with%20careful%20monitoring%20of%20the%20immunosuppressive%20therapy.%20The%20outcome%20was%20favorable.%5CnDiscussion%20and%20conclusion%5CnAlthough%20infrequent%20in%20kidney%20transplant%20recipients%2C%20NTM%20can%20cause%20pulmonary%20infection%20several%20years%20after%20transplantation.%20Treatment%20of%20M.%20xenopi%20infection%20relies%20on%20a%20multidrug%20regimen%20with%20at%20least%203%20antimycobacterial%20drugs.%20Drug-drug%20interactions%20between%20immunosuppressive%20treatments%20and%20rifamycins%20require%20careful%20dose%20adjustment%20and%20monitoring%20to%20avoid%20graft%20rejection.%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.idcr.2022.e01675%22%2C%22ISSN%22%3A%222214-2509%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2214250922003031%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T15%3A07%3A26Z%22%7D%7D%2C%7B%22key%22%3A%226W5JQ546%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khan%20and%20Guglielmetti%22%2C%22parsedDate%22%3A%222023-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKhan%2C%20U.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%3Cb%3ETailored%20TPT%20for%20drug-resistant%20TB%20-%20promoting%20equity%20and%20access%20to%20optimal%20care%3C%5C%2Fb%3E.%20Int%20J%20Tuberc%20Lung%20Dis%20%3Ci%3E27%3C%5C%2Fi%3E%2C%2089b%26%23x2013%3B890%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0538%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.22.0538%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tailored%20TPT%20for%20drug-resistant%20TB%20-%20promoting%20equity%20and%20access%20to%20optimal%20care%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222023-01-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.22.0538%22%2C%22ISSN%22%3A%221815-7920%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-03-10T14%3A58%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22GXEAIVT5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Masini%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMasini%2C%20T.%2C%20Furin%2C%20J.%2C%20Udwadia%2C%20Z.%20and%20Guglielmetti%2C%20L.%20%282023%29.%20%3Cb%3EOptimal%20management%20of%20drug-resistant%20tuberculosis%3A%20Can%20India%20lead%20the%20way%3F%3C%5C%2Fb%3E%20Indian%20Journal%20of%20Medical%20Research%20%3Ci%3E157%3C%5C%2Fi%3E%2C%20220%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmr.ijmr_300_23%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmr.ijmr_300_23%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimal%20management%20of%20drug-resistant%20tuberculosis%3A%20Can%20India%20lead%20the%20way%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiziana%22%2C%22lastName%22%3A%22Masini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Furin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%5D%2C%22abstractNote%22%3A%22An%20abstract%20is%20unavailable.%22%2C%22date%22%3A%22Feb-Mar%202023%22%2C%22language%22%3A%22en-US%22%2C%22DOI%22%3A%2210.4103%5C%2Fijmr.ijmr_300_23%22%2C%22ISSN%22%3A%220971-5916%20%28Print%29%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.lww.com%5C%2Fijmr%5C%2FFulltext%5C%2F2023%5C%2F02000%5C%2FOptimal_management_of_drug_resistant_tuberculosis_.17.aspx%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222023-06-28T12%3A40%3A38Z%22%7D%7D%5D%7D
Aubry, A. and Veziris, N. (2023). La tuberculose, l’une des plus anciennes maladies infectieuses : quelles avancées récentes majeures ? Med Sci (Paris) 39, 203–204, http://doi.org/10.1051/medsci/2023054.
Barbier, E., Fouchet, T., Hartmann, A., Cambau, E., Mougari, F., Dubois, C., Lubetzki, M. and Rochelet, M. (2023). Rapid electrochemical detection of Mycobacterium tuberculosis in sputum by measuring Ag85 activity with disposable carbon sensors. Talanta 253, 123927, http://doi.org/10.1016/j.talanta.2022.123927.
Campbell, J. R., Chan, E. D., Anderson, L. F., Bonnet, M., Brode, S. K., Cegielski, J. P., Guglielmetti, L., Singla, R., Fox, G. J., Skrahina, A., Rodrigues, D., Kuksa, L., Viiklepp, P. and Menzies, D. (2023). Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes. The International Journal of Tuberculosis and Lung Disease 27, 338–340, http://doi.org/10.5588/ijtld.22.0678.
Domínguez, José, Boeree, M. J., Cambau, E., Chesov, D., Conradie, F., Cox, V., Dheda, K., Dudnyk, A., Farhat, M. R., Gagneux, S., Grobusch, M. P., Gröschel, M. I., Guglielmetti, L., Kontsevaya, I., Lange, B., van Leth, F., Lienhardt, C., Mandalakas, Anna M, Maurer, F. P., Merker, M., Miotto, P., Molina-Moya, B., Morel, F., Niemann, S., Veziris, N., Whitelaw, A., Horsburgh, Charles R, Lange, C., Domínguez, Jose, Boeree, M. J., Cambau, E., Chesov, D., Conradie, F., Cox, V., Dheda, K., Dudnyk, A., Farhat, M. R., Gagneux, S., Grobusch, M. P., Gröschel, M. I., Guglielmetti, L., Kontsevaya, I., Lange, B., van Leth, F., Lienhardt, C., Mandalakas, Anna Maria, Maurer, F., Merker, M., Miotto, P., Molina-Moya, B., Morel, F., Niemann, S., Veziris, N., Whitelaw, A., Horsburgh, Charles Robert and Lange, C. (2023). Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. The Lancet Infectious Diseases, http://doi.org/10.1016/S1473-3099(22)00875-1.
Faury, H. B., Awad, Z., Jolivet, S., Neindre, K. L., Couturier, J., Godmer, A., Colle, R., Levi, L. I., Cambau, E. and Barbut, F. (2023). Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit. Infection Control & Hospital Epidemiology 1–3, http://doi.org/10.1017/ice.2022.263.
Fröberg, G., Maurer, F. P., Chryssanthou, E., Fernström, L., Benmansour, H., Boarbi, S., Mengshoel, A. T., Keller, P. M., Viveiros, M., Machado, D., Fitzgibbon, M. M., Mok, S., Werngren, J., Cirillo, D. M., Alcaide, F., Hyyryläinen, H.-L., Aubry, A., Andres, S., Nadarajan, D., Svensson, E., Turnidge, J., Giske, C. G., Kahlmeter, G., Cambau, E., van Ingen, J. and Schön, T. (2023). Towards clinical breakpoints for non-tuberculous mycobacteria – Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical Microbiology and Infection, http://doi.org/10.1016/j.cmi.2023.02.007.
Günther, G., Guglielmetti, L., Leu, C., Lange, C., van Leth, F., Hasan Hafizi, Khachatryan, N., Aroyan, H., Kabasakalyan, E., Knappik, M., Skrahina, A., Klimuk, D., Nikolenka, A., Muylle, I., Milanov, V., Velkovska, D., Tarinska, N., Bachiyska, E., Jankovic, M., Pieridou, D., Adamide, T., Nicolaou, N., Vasakova, M., Sukholytka, M., Kopeckà, E., Folkvardsen, D. B., Svensson, E., Danilovits, M., Kummik, T., Vasankari, T., Fréchet-Jachym, M., Nahmiash, A., Togonidze, T., Avaliani, Z., Kinkladze, I., Aspindzelashvili, R., Bichashvili, T., Losaberidze, G., Merabishvili, T., Kalsdorf, B., Manika, K., Tsiakitzis, K., Bakos, A., Ægisdóttir, T. R., Michelsen, G. S., Karlsdóttir, K., McLaughlin, A.-M., Fitzgibbon, M., Chemtob, D., Codecasa, L. R., Ferrarese, M., Torri, S., Gjocaj, M., Kuksa, L., Davidaviciene, E., Wirtz, G., Perrin, M., Asciak, A. P., Chesov, D., de Lange, W., Akkerman, O., Poposka, B. I., Mack, U., Jensenius, M., Kvalvik, L., Mengshoel, A. T., Kruczak, K., Duarte, R., Ribeiro, N., Ibraim, E., Kaluzhenina, A., Barkanova, O., Pesut, D., Solovic, I., Svetina, P., Souza-Galvão, M.-L. de, Millet, J.-P., Casas, X., Vives, M., Bruchfeld, J., Dalemo, P., Jonsson, J., Aeschbacher, K., Keller, P., Özkara, S., Tiberi, S., Chen, C., Terleeva, Y. and Dudnyk, A. (2023). Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical Microbiology and Infection 29, 77–84, http://doi.org/10.1016/j.cmi.2022.07.026.
Günther, G., Guglielmetti, L., Leu, C., van Leth, F. and Lange, C. (2023). Relative cost of multidrug-resistant TB medicines in Europe. The International Journal of Tuberculosis and Lung Disease 27, 341–344, http://doi.org/10.5588/ijtld.23.0026.
Guthmann, J.-P., Fraisse, P., Bonnet, I. and Robert, J. (2023). Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022. Eurosurveillance 28, http://doi.org/10.2807/1560-7917.ES.2023.28.12.2300155.
Hamon, A., Liegeon, G., Louis, K., Cambau, E. and De Castro, N. (2023). Atypical presentation of Mycobacterium xenopi pulmonary infection in a kidney transplant recipient: A case report and literature review. IDCases 31, e01675, http://doi.org/10.1016/j.idcr.2022.e01675.
Khan, U. and Guglielmetti, L. (2023). Tailored TPT for drug-resistant TB - promoting equity and access to optimal care. Int J Tuberc Lung Dis 27, 89b–890, http://doi.org/10.5588/ijtld.22.0538.
Masini, T., Furin, J., Udwadia, Z. and Guglielmetti, L. (2023). Optimal management of drug-resistant tuberculosis: Can India lead the way? Indian Journal of Medical Research 157, 220, http://doi.org/10.4103/ijmr.ijmr_300_23.